Login to South West London Pathology Services

If you have any queries about pathology consumables – you need a new account or you have a query about your order, please telephone 020 8266 6827. Forgotten your password

Microbiology

Our microbiology laboratories, based at St George’s Hospital, use sophisticated automated equipment alongside a wide range of advanced techniques to detect, identify and treat infections and to prevent the spread of infection. We specialise in:

  • bacteriology
  • virology
  • molecular diagnostics
  • mycology
  • parasitology.

Read the flow chart for ordering urgent or out-of-hours microbiology tests (hospital only)

There has been great investment in new technology within microbiology. The laboratory is now one of the most advanced in the UK and has been visited by private healthcare companies from the UK, Europe, China and Australia as well as other NHS hospitals.

We offer:

  • dedicated operational and clinical support
  • a fully UKAS accredited laboratory
  • logistical set up and results reporting to meet your requirements.

Our clinical advice service for all diagnostic results is available 24 hours a day, seven days a week.

Covid-19

Our virology laboratories have been at the forefront of Covid-19 antibody and antigen testing since the outbreak began in 2020, during which time we have tested thousands of samples. At the outset of the pandemic, our team of clinical scientists rapidly validated new assays and workflows for molecular testing, completing the work in a short timeframe to allow testing to begin.

As testing methodologies and technologies have changed over the course of the pandemic, we have been able to offer quicker, more accurate testing, reducing the turnaround time for the antigen test to between 24 to 48 hours. We have invested in the most cutting-edge equipment to allow us to offer the best possible service and to provide resilience by using a number of different testing platforms.

Molecular diagnostics

Molecular diagnostics is a rapidly developing area in healthcare and will have a dramatic impact on the speed, efficiency and accuracy of diagnostic medicine.

We were one of the first hospital laboratories in the UK to have acquired a fully automated molecular diagnostics system, giving us the technology to detect pathogens quickly and accurately enabling patients to receive their diagnosis and treatment faster.

One molecular technique we have been using for many years is Polymerase Chain Reaction (PCR). Our current repertoire using PCR includes:

  • Covid-19
  • norovirus
  • Chlamydia trachomatis and Neisseria gonorrhoeae
  • Trichomonas vaginalis and Mycoplasma genitalium
  • CSF viruses
  • Respiratory viruses
  • quantitative HIV, HCV, HBV viral loads
  • MRSA
  • Carbapenemase resistance.

Our fully automated analysers can deliver results efficiently and quickly with the ability to deliver 300 results in less than three and a half hours.

In addition, we can process 24 different molecular disease states simultaneously for same day testing.

Latent TB

We have significant capacity to carry out latent TB testing using the Quantiferon Gold Plus testing method. Using this technology, we are able to run many tests a day, with an average turnaround time of three to five days.

In support of this service we have  clinical expertise from leading TB experts at St George’s University Hospital NHS Foundation Trust.

Faecal Immunochemical Test (FIT)

We perform FIT testing for seven boroughs in London, offering a complete service including distribution of the kits, processing the specimens and managing results. We are able to provide results within 48 hours.

Blood borne pathogens

We have developed an innovative solution to blood borne pathogen screening using capillary blood testing (CBT) – this is less invasive and requires smaller amounts of blood than venous sampling by phlebotomy. Samples can easily be taken in the community and sample quality is retained by additives in the sample tube. The sample remains liquid and retains the ability to offer quantitative results for monitoring infectious disease pathogens.

Our UKAS accredited dilution technique allows multiple tests to be carried out on a single CBT sample which includes antibodies, antigens and either DNA or RNA testing on the same capillary blood sample.

Latest news

November 19, 2024

A day in the life of Simon Brewer, managing director at South West London Pathology

For Simon, no two days are alike. From back-to-back meetings to site visits, his role balances strategic planning with on-the-ground problem-solving. “I prefer being in the labs,” he says, valuing direct engagement with frontline staff to inform decisions.

Nicknamed “Captain Chaos” for his knack for shaking up the status quo, Simon thrives on driving innovation and keeping SWLP moving forward as a dynamic, people-focused service.

Read more
November 13, 2024

Celebrating Haval Ozgun’s leadership in point of care testing and community diagnostics

Haval Ozgun, SWLP’s General Manager of Rapid Diagnostics and POCT, recently represented our work at a high-level discussion in Stormont Parliament. His insights on expanding community diagnostics underscored the critical role of POCT in enhancing patient care, preventing hospital admissions, and aligning with NHS goals for proactive health solutions. Thank you, Haval, for your dedication and leadership!

Read more
November 12, 2024

Meet Dr Nilukshi Wijesuriya, the new clinical lead for Cellular Pathology

Dr. Nilukshi Wijesuriya, affectionately known as “Nilu” by her colleagues, has recently taken on the role of clinical lead for Cellular Pathology at South West London Pathology. Celebrated for her dedication and innovative thinking, Nilu shares insights into her unique career journey, her compassionate approach to leadership, and her vision to tackle challenges facing her team.

Read more
November 12, 2024

Pathology service enhancement: New molecular analysers now live in microbiology

South West London Pathology (SWLP) is excited to announce a significant upgrade in Microbiology with the launch of new, advanced molecular analysers. This enhancement is part of SWLP’s ongoing commitment to advancing diagnostic capabilities and improving patient care. These state-of-the-art analysers are designed to streamline processes, enhance efficiency, and reduce error rates, providing more accurate […]

Read more